DR. DOUGLAS LYTLE MAYERS, M.D.
Hospitals at Wisconsin Ave, Bethesda, MD
License number
Maryland 0101033418
Category
Hospitals
Type
Military Hospital
Address
Address
2
8901 Wisconsin Ave, Bethesda, MD 20889
9 Oak Ridge Dr, Newtown, CT 06470
9 Oak Ridge Dr, Newtown, CT 06470
Phone
(301) 295-4237
(301) 295-2992 (Fax)
(203) 270-1551
(203) 798-4336 (Fax)
(301) 295-2992 (Fax)
(203) 270-1551
(203) 798-4336 (Fax)
Professional information
Douglas Lytle Mayers, Bethesda MD
Specialties:
Internist
Address:
8901 Wisconsin Ave, Bethesda, MD 20889
Education:
University of Pennsylvania, Perelman School of Medicine - Doctor of Medicine
National Naval Medical Center - Fellowship - Infectious Disease (Internal Medicine)
University of Virginia Health System - Residency - Internal Medicine
National Naval Medical Center - Fellowship - Infectious Disease (Internal Medicine)
University of Virginia Health System - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)
Douglas Lytle Mayers, Bethesda MD
Specialties:
Internal Medicine, Infectious Disease
Work:
National Naval Medical Center - Bethesda
8901 Wisconsin Ave, Bethesda, MD
8901 Wisconsin Ave, Bethesda, MD
Education:
University of Pennsylvania(1978)
Treatment Of Hiv Infection Through Combined Administration Of Tipranavir And Capravirine
US Patent:
2005002, Jan 27, 2005
Filed:
Nov 24, 2003
Appl. No.:
10/720550
Inventors:
Ulrich Drees - Ingelheim, DE
Douglas Mayers - Newtown CT, US
Scott McCallister - Westport CT, US
Douglas Mayers - Newtown CT, US
Scott McCallister - Westport CT, US
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
International Classification:
A61K031/7056, A61K031/522
US Classification:
514043000, 514263320
Abstract:
An improved method for treating HIV infection comprising administering to a human in need of such treatment a combination of a therapeutically effective amount of tipranavir or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of capravirine or a pharmaceutically acceptable salt thereof.
Pharmaceutical Composition Of Antiviral Agents
US Patent:
2004023, Nov 25, 2004
Filed:
Mar 25, 2004
Appl. No.:
10/809609
Inventors:
Heinz-Gerd Klaes - Gau-Bickelheim, DE
Elena Koundourakis - Danbury CT, US
Hernan Valdez - Somers NY, US
Douglas Mayers - Newtown CT, US
Elena Koundourakis - Danbury CT, US
Hernan Valdez - Somers NY, US
Douglas Mayers - Newtown CT, US
Assignee:
Boehringer Ingelheim International GmbH - Ingelheim
International Classification:
A61K031/7076, A61K031/7072, A61K031/551
US Classification:
514/045000, 514/046000, 514/050000, 514/220000
Abstract:
In accordance with the present invention there is provided a pharmaceutical composition useful for the treatment or prophylaxis of viral infections comprising a compound of the formula (I)
and at least one antiviral active compound of the formula (II)
wherein Base is selected from the group consisting of thymine, cytosine, adenine, guanine, inosine, uracil, 5-ethyluracil and 2,6-diaminopurine.
Method For Treating Hiv Infection Through Co-Administration Of Tipranavir And Gw873140
US Patent:
2006016, Jul 20, 2006
Filed:
Nov 17, 2005
Appl. No.:
11/281020
Inventors:
Michael Kraft - Mainz, DE
Douglas Mayers - Newtown CT, US
Douglas Mayers - Newtown CT, US
Assignee:
Boehringer Ingelheim International GmbH - Ingelheim
International Classification:
A61K 31/4433
US Classification:
514336000
Abstract:
A method for treating HIV infection through co-administration of tipranavir and GW873140.
Pharmaceutical Composition Of Antiviral Agents
US Patent:
2004023, Nov 25, 2004
Filed:
Mar 25, 2004
Appl. No.:
10/809250
Inventors:
Heinz-Gerd Klaes - Gau-Bickelheim, DE
Elena Koundourakis - Danbury CT, US
Hernan Valdez - Somers NY, US
Douglas Mayers - Newtown CT, US
Elena Koundourakis - Danbury CT, US
Hernan Valdez - Somers NY, US
Douglas Mayers - Newtown CT, US
Assignee:
Boehringer Ingelheim International GmbH - Ingelheim
International Classification:
A61K031/7076, A61K031/7072
US Classification:
514/045000, 514/046000, 514/050000
Abstract:
In accordance with the present invention there is provided a pharmaceutical composition useful for the treatment or prophylaxis of viral infections comprising nevirapine and at least one antiviral active compound of formula (I)
wherein Base is selected from the group consisting of thymine, cytosine, adenine, guanine, inosine, uracil, 5-ethyluracil and 2,6-diaminopurine, or a pharmaceutically acceptable salt or prodrug thereof.
Method For Treating Hiv Infection Through Co-Administration Of Tipranavir And Sch-417690
US Patent:
2006013, Jun 22, 2006
Filed:
Nov 17, 2005
Appl. No.:
11/280995
Inventors:
Michael Kraft - Mainz, DE
Douglas Mayers - Newtown CT, US
Douglas Mayers - Newtown CT, US
Assignee:
Boehringer Ingelheim International GmbH - Ingelheim
International Classification:
A61K 31/4433
US Classification:
514336000
Abstract:
A method for treating HIV infection through co-administration of tipranavir and SCH-417690.
Method For Treating Hiv Infection Through Co-Administration Of Tipranavir And Gw695634
US Patent:
2006014, Jun 29, 2006
Filed:
Nov 16, 2005
Appl. No.:
11/280707
Inventors:
Michael Kraft - Mainz, DE
Douglas Mayers - Newtown CT, US
Douglas Mayers - Newtown CT, US
Assignee:
Boehringer Ingelheim International GmbH - Ingelheim
International Classification:
A61K 31/4433
US Classification:
514336000
Abstract:
A method for treating HIV infection through co-administration of tipranavir and GW695634.
Pharmaceutical Composition Of Antiviral Agents
US Patent:
2004023, Nov 25, 2004
Filed:
Mar 25, 2004
Appl. No.:
10/809060
Inventors:
Heinz-Gerd Klaes - Gau-Bickelheim, DE
Elena Koundourakis - Danbury CT, US
Hernan Valdez - Somers NY, US
Douglas Mayers - Newtown CT, US
Elena Koundourakis - Danbury CT, US
Hernan Valdez - Somers NY, US
Douglas Mayers - Newtown CT, US
Assignee:
Boehringer Ingelheim International GmbH - Ingelheim
International Classification:
A61K031/7076, A61K031/7072
US Classification:
514/045000, 514/046000, 514/050000
Abstract:
In accordance with the present invention there is provided a pharmaceutical composition useful for the treatment or prophylaxis of viral infections comprising tipranavir and at least one antiviral active compound of formula (I)
wherein Base is selected from the group consisting of thymine, cytosine, adenine, guanine, inosine, uracil, 5-ethyluracil and 2,6-diaminopurine, or a pharmaceutically acceptable salt or prodrug thereof.
Method For Treating Hiv Infection Through Co-Administration Of Tipranavir And Darunavir
US Patent:
2006013, Jun 22, 2006
Filed:
Nov 14, 2005
Appl. No.:
11/273525
Inventors:
Micheal Kraft - Mainz, DE
Douglas Mayers - Newtown CT, US
Douglas Mayers - Newtown CT, US
Assignee:
Boehringer Ingelheim International GmbH - Ingelheim
International Classification:
A61K 31/4433
US Classification:
514336000
Abstract:
A method for treating HIV infection through co-administration of tipranavir and darunavir.